DEBx Medical
The company develops and manufactures DEBRICHEM, a topical chemical debridement agent designed to eliminate biofilm and infection from hard-to-heal wounds. The product is applied by healthcare professionals in ambulatory or clinical settings to prepare the wound bed for healing in a single 60-second application. It serves as an alternative to surgical debridement for patients suffering from chronic wounds, such as diabetic foot ulcers and necrotizing fasciitis.
Visit websiteAmsterdam, Netherlands
Healthtech
Medtech
Medical Devices
Funding summary
- Total raised
- €10.0M
- Funding rounds
- 1
Investors in DEBx Medical
Investors on record for DEBx Medical. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like DEBx Medical?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors